LDOC1, a novel biomarker of prognosis in chronic lymphocytic leukemia
Başlık çevirisi mevcut değil.
- Tez No: 400490
- Danışmanlar: DR. LYNNE V. ABRUZZO
- Tez Türü: Doktora
- Konular: Hematoloji, Onkoloji, Hematology, Oncology
- Anahtar Kelimeler: Belirtilmemiş.
- Yıl: 2011
- Dil: İngilizce
- Üniversite: The University of Texas Health Science Center at Houston
- Enstitü: Yurtdışı Enstitü
- Ana Bilim Dalı: Belirtilmemiş.
- Bilim Dalı: Belirtilmemiş.
- Sayfa Sayısı: 115
Özet
.
Özet (Çeviri)
In chronic lymphocytic leukemia (CLL), one of the best predictors of outcome is the somatic mutation status of the immunoglobulin heavy chain variable region (IGHV) genes. Patients whose CLL cells have unmutated IGHV genes have a median survival of 8 years; those with mutated IGHV genes have a median survival of 25 years. To identify new prognostic biomarkers and molecular targets for therapy in untreated CLL patients, we reanalyzed the raw data from four published gene expression profiling microarray studies. Of 88 candidate biomarkers associated with IGHV somatic mutation status, we identified LDOC1 (Leucine Zipper, Down-regulated in Cancer 1), as one of the most significantly differentially expressed genes that distinguished mutated from unmutated CLL cases. LDOC1 is a putative transcription factor of unknown function in B-cell development and CLL pathophysiology. Using a highly sensitive quantitative RT-PCR (QRT-PCR) assay, we confirmed that LDOC1 mRNA was dramatically down-regulated in mutated compared to unmutated CLL cases. Expression of LDOC1 mRNA was also strongly associated with other markers of poor prognosis, including ZAP70 protein and cytogenetic abnormalities of poor prognosis (deletions of chromosomes 6q21, 11q23, and 17p13.1, and trisomy 12). CLL cases positive for LDOC1 mRNA had significantly shorter overall survival than negative cases. Moreover, in a multivariate model, LDOC1 mRNA expression predicted overall survival better than IGHV mutation status or ZAP70 protein, among the best markers of prognosis in CLL. We also discovered LDOC1S, a new LDOC1 splice variant. Using isoform-specific QRT-PCR assays that we developed, we found that both isoforms were expressed in normal B cells (naïve > memory), unmutated CLL cells, and in B-cell non-Hodgkin lymphomas with unmutated IGHV genes. To investigate pathways in which LDOC1 is involved, we knocked down LDOC1 in HeLa cells and performed global gene expression profiling. GFI1 (Growth Factor-Independent 1) emerged as a significantly up-regulated gene in both HeLa cells and CLL cells that expressed high levels of LDOC1. GFI1 oncoprotein is implicated in hematopoietic stem cell maintenance, lymphocyte development, and lymphomagenesis. Our findings indicate that LDOC1 mRNA is an excellent biomarker of overall survival in CLL, and may contribute to B-cell differentiation and malignant transformation.
Benzer Tezler
- Dört ayaklı robotların mekanik modellemesi ve aerodinamik analizi
Mechanical modeling and aerodynamic analysis of four-leged robots
ENES UZUN
Yüksek Lisans
Türkçe
2024
Mühendislik BilimleriOndokuz Mayıs ÜniversitesiAkıllı Sistemler Mühendisliği Ana Bilim Dalı
DOÇ. DR. CENGİZ TEPE
- Vektör kontrollü sürekli mıknatıslı senkron motor sürücü ve fırçasız DC motor sürücü düzeneklerinin analizi ve simülasyonu
The Analysis and simulations of vector controlled permanent magnet synchronous motor and brushless DC motor drive system
UMUT DEMİREZEN
Yüksek Lisans
Türkçe
2002
Elektrik ve Elektronik MühendisliğiGazi ÜniversitesiElektrik ve Elektronik Mühendisliği Ana Bilim Dalı
YRD. DOÇ. DR. M. TİMUR AYDEMİR
- Disfonksiyonel uterin kanama tedavisinde düşük doz östrojenli oral kontraseptifler ve uzun etkili GnRH analogları ile kombinasyonunun karşılaştırılması (klinik, randomize, prospektif çalışma)
Başlık çevirisi yok
NADİRE NİHAN ÇETİN
Tıpta Uzmanlık
Türkçe
2002
Kadın Hastalıkları ve DoğumGazi ÜniversitesiKadın Hastalıkları ve Doğum Ana Bilim Dalı
PROF.DR. ONUR KARABACAK